CDC Seeks Public Input on Enhanced Andes Hantavirus Surveillance for Cruise Passengers and Travelers
A significant federal public health development is underway as the Centers for Disease Control and Prevention CDC moves to formalize a new information collection initiative. This effort focuses on monitoring cruise ship passengers and other international travelers for potential exposure to Andes hantavirus. Published in the Federal Register on June 10, 2026, the notice invites public comment on the proposed "2026 Andes Hantavirus Cruise Passenger and Traveler Contact Monitoring" project, which aims to bolster the nation's capacity to detect, investigate, and control outbreaks of this serious disease. The CDC's proposal highlights a proactive stance against communicable diseases that pose risks across international borders and within domestic travel networks.
The Threat of Andes Hantavirus and CDC's Mandate
Hantaviruses are a group of viruses carried by rodents that can cause severe, sometimes fatal, diseases in humans. While most hantaviruses in the United States are transmitted through contact with infected rodent droppings, the Andes hantavirus, primarily found in South America, is unique and particularly concerning due to its proven capability for person-to-person transmission. This characteristic elevates its potential for rapid spread, especially in confined environments like cruise ships or during extensive international travel.
The CDC's authority to implement such surveillance measures stems from Section 361 of the Public Health Service Act 42 U.S.C. 264. This foundational legislation empowers the Secretary of Health and Human Services to issue and enforce regulations vital for preventing the introduction, transmission, or spread of communicable diseases into the United States from foreign countries. The Division of Global Migration Health DGMH within the CDC's National Center for Emerging and Zoonotic Infectious Diseases NCEZID is tasked with fulfilling this responsibility, operating Port Health Stations and administering foreign quarantine regulations outlined in 42 Code of Federal Regulation part 71. These regulations specifically include public health prevention measures to detect communicable diseases among travelers. The proposed data collection directly supports these statutory and regulatory duties, enabling the CDC to conduct health screenings of travelers upon arrival and assess public health risks following reports of illness.
Details of the Proposed Monitoring Program
The core objective of the 2026 Andes Hantavirus monitoring program is multifaceted. It seeks to conduct comprehensive case investigations and actively monitor individuals identified as contacts during hantavirus exposure events, whether these events occur domestically or internationally. A critical component involves analyzing epidemiologic, clinical, and laboratory data from both confirmed cases and their contacts. This analysis is designed to thoroughly characterize exposure events, pinpoint transmission patterns including person-to-person spread for the Andes virus, and ultimately inform effective control strategies.
Furthermore, the collected information will be used to generate detailed reports. These reports will describe demographic characteristics of affected individuals, their clinical presentation, and critical timelines such as the duration from exposure to symptom onset and from symptom onset to detection. Such data is invaluable for guiding real-time response decision-making during an outbreak. The insights gained from this monitoring will also play a crucial role in developing future guidance and recommendations for managing travelers post-arrival, not only for the current Andes hantavirus outbreak but also for future outbreaks involving other high-consequence pathogens.
The proposed data collection instruments include specific assessment surveys. These are identified as the "Canary Island Assessment" for cruise ship passengers, an "Andes Virus Guidance Assessment" for passengers and high-risk contacts, and "Hantavirus 2026 Monitoring Schema Data Elements" which involve daily monitoring over 42 days for high-risk contacts.
Interagency Collaboration and Public Health Partnerships
A significant aspect of this initiative involves close collaboration between the CDC and state and local health departments. The CDC currently shares case and contact information, alongside public health assessments of hantavirus exposure risk, with state and local partners using established data-sharing infrastructure. These local health departments are then critical in utilizing this contact information. They prioritize and determine the necessary level of follow-up based on the assessed risk of exposure to confirmed and probable hantavirus cases. Their work includes contacting travelers to ascertain if they are symptomatic and if additional screening and testing for hantavirus are required.
The proposed data collection, particularly through the assessment surveys, aims to further enhance this partnership. It will provide state and local health departments with more comprehensive information regarding case and contact traveler monitoring activities. This, in turn, will help evaluate the usability and effectiveness of the public health risk assessment information provided by the CDC, ensuring the implementation of appropriate and effective outbreak control measures at the local level.
Regulatory Context and Opportunity for Public Input
This data collection proposal falls under the purview of the Paperwork Reduction Act of 1995 PRA. This federal statute mandates that agencies obtain approval from the Office of Management and Budget OMB for any information collection they conduct or sponsor. A key requirement of the PRA is that federal agencies provide a 60-day notice in the Federal Register for any proposed new or extended information collection. This notice serves to solicit public comments before submitting the collection for OMB approval.
The OMB is particularly interested in comments that address several key areas: whether the proposed collection is necessary and has practical utility for the agency's functions; the accuracy of the agency's estimated burden of the collection; ways to enhance the quality, utility, and clarity of the information collected; methods to minimize the burden on respondents through technological means; and an assessment of information collection costs. The CDC estimates the annualized burden for respondents, primarily cruise ship passengers and high-risk contacts, to be 17,813 hours, with no cost incurred by respondents other than their time.
The opportunity for public comment, which closes on August 10, 2026, provides a vital mechanism for stakeholders, including legal professionals, policymakers, and the general public, to weigh in on the scope, methodology, and potential impact of this crucial public health surveillance program.
